NEW YORK (GenomeWeb News) – As part of a new push to become a leading player in synthetic biology, the UK has provided £5.3 million ($8 million) to fund 15 new synthetic biology technology development projects at a number of companies.

The funding will fuel an array of tech development efforts at about a dozen companies. The grant winners were chosen through a competition for projects that will be led by businesses seeking to demonstrate the feasibility of using synthetic biology to create new products and processes or improve older ones.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.